Page 2 of 3.
HalioDx, an immuno-oncology...
HalioDx, an immuno-oncology company pioneering the immunological diagnosis of cancers, today announced that the company...
HalioDx, an immuno-oncology diagnostic company pioneering the immunological diagnosis of cancers with Immunoscore® and...
HalioDx SAS, an immuno-oncology diagnostic company, today announced that Gencell Pharma will market and distribute...
HalioDx SAS, an immuno-oncology diagnostic company, today announced that Pronto Diagnostics will market and distribute...
HalioDx SAS, an immuno-oncology diagnostic company, today announced that it has signed a distribution agreement with...
HalioDx SAS, an immuno-oncology diagnostic company, announced today that Everything Genetic Ltd. will market and...
• An international consortium confirms the strong prognostic value of the Immunoscore® assay in early stage colon...
HalioDx SAS, an immuno-oncology diagnostic company, today announced that Immunoscore® Colon CE-IVD workflow is now...
• COLOSSUS aim is to better stratify metastatic colorectal patients for improving treatments
• The project gathers a...